| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |